Category Language

The Legal Implications Of Medicinal Marijuana As A Geographical Indication For Jamaica

Although there are ongoing negotiations to revise the Lisbon Agreement for the international recognition of GIs, there is currently no uniform reciprocal legal recognition for non-wine and spirit GIs in international jurisdictions. Jamaica’s Cannabis (hereafter marijuana), is identified by its government as one of the country’s products which is domestically GI registrable, writes Marsha Cadogan.

Why The Request By Least Developed Countries For An Extension Of The Transitional Period For Granting And Enforcing Medicines Patents Needs To Be Supported

Ellen 't Hoen writes: On 24 February 2015 Bangladesh on behalf of the 34 Least Developed Country members (LDCs) of the World Trade Organization (WTO) submitted a request for an extension of the transitional period under article 66.1 TRIPS with respect to pharmaceutical products until the country is no longer classified as LDC.[1] The original extension, set to expire on 1st January 2016, specifically removes the obligation for LDCs to comply with Section 5 (Patents) and Section 7 (Protection of Undisclosed Information) of Part II of TRIPS, including any obligation to enforce rights under these provisions.

It is a little known fact that since the adoption of the 2001 Doha Declaration on TRIPS and Public Health, LDCs have frequently used the extension in day-to-day procurement of low cost generic medicines, in particular to access medicines needed for the treatment of HIV.

Tobacco Plain Packaging Discussion Lights Up Again At WTO

The issue of plain packaging for tobacco products as a health measure has been smouldering at the World Trade Organization since Australia decided to implement legislation requiring plain packaging in 2012. Now, as more countries seek to enact similar legal provisions, some tobacco producing countries continue to try to stub them out, including at the WTO intellectual property committee.

Medicines Patent Pool Nails Down Another Key Paediatric Drug

The Medicines Patent Pool today announced it has struck a licence with MSD, the North American-based Merck pharmaceutical company, to boost access to and innovation on raltegravir, a child-approved HIV medicine. The outcome is particularly significant because it opens options for very young children.

WIPO Members Propose Changes To Draft Legal Instrument Protecting GIs

In the run-up to the May high-level negotiating meeting to amend a World Intellectual Property Organization treaty to enhance the protection of geographical indications, member countries were invited to suggest changes to the basic negotiating text. Ten countries issued proposed changes by the 1 February deadline, some asking for full participation of WIPO members in the negotiations of the 28-member treaty.